COVID-19 and coagulopathy

被引：20
|
作者：
Sarkar, Malay [1 ]
Madabhavi, Irappa, V [2 ,3 ,4 ]
Pham Nguyen Quy [5 ]
Govindagoudar, Manjunath B. [6 ]
机构：
[1] Indira Gandhi Med Coll, Dept Pulm Med, Shimla, Himachal Prades, India
[2] Kerudi Canc Hosp, Dept Med & Pediat Oncol, Bagalkot, Karnataka, India
[3] JN Med Coll, Dept Med Oncol, Belagavi, Karnataka, India
[4] Nanjappa Hosp, Dept Med Oncol, Shimoga, Karnataka, India
[5] Kyoto Miniren Cent Hosp, Dept Med Oncol, Kyoto, Japan
[6] Pt BD Sharma Postgrad Inst Med Sci, Dept Pulm & Crit Care, Rohtak, Haryana, India
来源：
CLINICAL RESPIRATORY JOURNAL | 2021年 / 15卷 / 12期
关键词：
COVID-19; endotheliitis; heparin; microthrombosis; thrombosis; CORONAVIRUS DISEASE 2019; MEDICAL PATIENTS; INNATE IMMUNITY; THROMBOPROPHYLAXIS; COAGULATION; RIVAROXABAN; INFECTION; HEPARIN; METAANALYSIS; PROPHYLAXIS;
D O I：
10.1111/crj.13438
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
The SARS-CoV-2 is a new coronavirus responsible for the COVID-19 disease and has caused the pandemic worldwide. A large number of cases have overwhelmed the healthcare system worldwide. The COVID-19 infection has been associated with a heightened risk of thromboembolic complications. Various mechanisms are leading to the high thrombotic risk in COVID-19 patients such as inflammation, endotheliitis, hyperviscosity, and hypercoagulability. We searched PubMed, EMBASE, and CINAHL from January 2020 to December 2020. We used the following search terms: COVID-19, coagulopathy, and thrombosis. We reviewed the epidemiology, clinical features, mechanisms, and treatment of COVID-19-associated coagulopathy.
引用
收藏
页码：1259 / 1274
页数：16
相关论文
共 50 条
  • [1] Coagulopathy and COVID-19
    Lorini, Ferdinando Luca
    Di Matteo, Maria
    Gritti, Paolo
    Grazioli, Lorenzo
    Benigni, Alberto
    Zacchetti, Lucia
    Bianchi, Isabella
    Fabretti, Fabrizio
    Longhi, Luca
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0E) : E95 - E98
  • [2] Coagulopathy and COVID-19
    Yazici, Onur
    Bozkus, Fulsen
    Demirci, Nilgun
    Gulhan, Pinar Yildiz
    Coskun, Funda
    [J]. EURASIAN JOURNAL OF PULMONOLOGY, 2020, 22 (04) : 67 - 69
  • [3] Coagulopathy in COVID-19
    Iba, Toshiaki
    Levy, Jerrold H.
    Levi, Marcel
    Thachil, Jecko
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2020, 18 (09) : 2103 - 2109
  • [4] Coagulopathy and COVID-19
    Ploplis, Victoria A.
    [J]. CURRENT DRUG TARGETS, 2022, 23 (17) : 1537 - 1538
  • [5] COVID-19 Coagulopathy
    Rettew, Andrew
    Garrahy, Ian
    Rahimian, Shoja
    Brown, Rebecca
    Sangha, Navdeep
    [J]. LIFE-BASEL, 2024, 14 (08):
  • [6] Coagulopathy in COVID-19
    Lio, Ka U.
    Rali, Parth
    [J]. LUNG INDIA, 2021, 38 (07) : S53 - S57
  • [7] COVID-19 coagulopathy
    Katyal, Anup
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (12) : 712 - 712
  • [8] Studying the coagulopathy of COVID-19
    Spyropoulos, Alex C.
    Bonaca, Marc P.
    [J]. LANCET, 2022, 399 (10320): : 118 - 119
  • [9] Thrombosis and Coagulopathy in COVID-19
    Gomez-Mesa, Juan Esteban
    Galindo-Coral, Stephania
    Montes, Maria Claudia
    Martin, Andres J. Munoz
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2021, 46 (03)
  • [10] COVID-19: Coagulopathy and thrombosis
    Mezalek, Z. Tazi
    [J]. REVUE DE MEDECINE INTERNE, 2021, 42 (02): : 93 - 100
12345